ZA200709516B - C. perfringens alpha toxoid vaccine - Google Patents

C. perfringens alpha toxoid vaccine

Info

Publication number: ZA200709516B
Authority: ZA; South Africa
Prior art keywords: toxoid vaccine; alpha toxoid; perfringens alpha; perfringens; vaccine
Prior art date: 2005-04-18

Application number

ZA200709516A

Other languages

English (en)

Inventor

Jayappa Huchappa

O'connell Kevin

Original Assignee

Schering Plough Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-18

Filing date

2007-11-05

Publication date

2008-11-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36820082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200709516(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-11-05 Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd

2008-11-26 Publication of ZA200709516B publication Critical patent/ZA200709516B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

ZA200709516A 2005-04-18 2007-11-05 C. perfringens alpha toxoid vaccine ZA200709516B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US67228905P	2005-04-18	2005-04-18

Publications (1)

Publication Number	Publication Date
ZA200709516B true ZA200709516B (en)	2008-11-26

Family

ID=36820082

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200709516A ZA200709516B (en)	2005-04-18	2007-11-05	C. perfringens alpha toxoid vaccine

Country Status (25)

Country	Link
US (2)	US8980283B2 (xx)
EP (1)	EP1874344B1 (xx)
JP (2)	JP5243951B2 (xx)
KR (1)	KR20080005277A (xx)
CN (1)	CN101198352B (xx)
AR (1)	AR054251A1 (xx)
AU (1)	AU2006236365B2 (xx)
BR (1)	BRPI0610843B1 (xx)
CA (1)	CA2606180C (xx)
CR (1)	CR9443A (xx)
DK (1)	DK1874344T3 (xx)
ES (1)	ES2583484T3 (xx)
IL (1)	IL186701A0 (xx)
MA (1)	MA29406B1 (xx)
MX (1)	MX2007013053A (xx)
MY (1)	MY149604A (xx)
NZ (1)	NZ562637A (xx)
PE (1)	PE20061398A1 (xx)
RU (1)	RU2434638C2 (xx)
SG (1)	SG186672A1 (xx)
TN (1)	TNSN07387A1 (xx)
TW (1)	TWI311057B (xx)
UA (1)	UA98099C2 (xx)
WO (1)	WO2006113772A1 (xx)
ZA (1)	ZA200709516B (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY149604A (en) *	2005-04-18	2013-09-13	Schering Plough Ltd	C.perfringens alpha toxoid vaccine
PT2004220E (pt) *	2006-03-30	2015-09-24	Zoetis Services Llc	Métodos e composições para vacinação de aves de capoeira
UA109105C2 (uk) *	2006-04-17	2015-07-27		Молекула нуклеїнової кислоти, що кодує істотно нетоксичний мутеїн альфа-токсину clostridium perfringens, та істотно нетоксичний мутеїн альфа-токсину clostridium perfringens
CA2667255A1 (en) *	2006-10-27	2008-05-08	Dow Agrosciences Llc	Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine
CA2669765A1 (en) *	2006-11-20	2008-05-29	Intervet International B.V.	Use of clostridium perfringens type c bacterium for the manufacture of a vaccine
US7820171B2 (en) *	2007-04-12	2010-10-26	Pradip Maiti	Use of avian anti-methanogen antibodies for reduction of methane production
WO2009000066A1 (en)	2007-06-22	2008-12-31	University Of Guelph	Vaccine against clostridium perfringens
US8956628B2 (en) *	2007-12-13	2015-02-17	Zoetis Products Llc	Bacteriophage preparations and method of use thereof
US9052304B2 (en)	2009-03-13	2015-06-09	Terrasep, Llc	Methods and apparatus for centrifugal liquid chromatography
WO2011103465A2 (en) *	2010-02-20	2011-08-25	Alexey Gennadievich Zdanovsky	Botulinum neurotoxin antigenic compositions and methods
WO2011151941A1 (ja) *	2010-06-04	2011-12-08	国立大学法人東京大学	制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CN102008720B (zh) *	2010-07-20	2015-02-25	东北农业大学	抗魏氏梭菌病转基因植物疫苗及其制作方法
US20140377248A1 (en) *	2011-12-23	2014-12-25	Merz Pharma Gmbh & Co. Kgaa	Method for the manufacturing of di-chain proteins for use in humans
CN102657683B (zh) *	2012-06-02	2014-05-07	哈尔滨工业大学	一种免疫类毒素的制备方法
CN102698259B (zh) *	2012-06-12	2017-02-08	北京中海生物科技有限公司	一种鸡坏死性肠炎（a型）灭活疫苗制备方法
CN102688484B (zh) *	2012-06-13	2016-03-30	北京中海生物科技有限公司	一种鸡坏死性肠炎（c型）灭活疫苗的生产方法
PL2911688T3 (pl)	2012-10-26	2020-03-31	Intervet International B.V.	Szczepionki zapewniające ochronę krzyżową przeciwko salmonelli
CN103463632B (zh) *	2013-09-05	2016-01-06	山东农业大学	牛羊肠毒血症的d型产气荚膜梭菌类毒素疫苗的制备方法
FR3012964A1 (fr) *	2013-11-12	2015-05-15	Seppic Sa	Vaccins adjuves pour vaccination aviaire in ovo
CN103861094A (zh) *	2014-03-27	2014-06-18	山东农业大学	一种产气荚膜梭菌α毒素基因工程疫苗及其应用
CN104131022A (zh) *	2014-08-01	2014-11-05	中国农业科学院兰州兽医研究所	产气荚膜梭菌α、β1、β2、ε毒素共表达载体及其构建方法和表达方法
CN104531731B (zh) *	2014-12-15	2018-06-26	中国人民解放军军事医学科学院军事兽医研究所	产气荚膜梭菌α毒素人源化单链抗体7D
CN104531730B (zh) *	2014-12-15	2018-07-17	中国人民解放军军事医学科学院军事兽医研究所	产气荚膜梭菌α毒素人源化单链抗体8B
CN104531867B (zh) *	2014-12-25	2017-03-29	湖北省农业科学院畜牧兽医研究所	产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒
EP3112474A1 (en) *	2015-06-29	2017-01-04	Evonik Degussa GmbH	Method of detecting avian necrotic enteritis
BR112019015140A2 (pt)	2017-01-23	2020-04-14	Univ Florida	indução de imunidade protetora contra antígenos
JP7161729B2 (ja) *	2017-02-28	2022-10-27	一般財団法人阪大微生物病研究会	多価ワクチン
CA3064461A1 (en) *	2017-05-31	2018-12-06	Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food	Vaccine against necrotic enteritis in poultry
WO2018224595A1 (en) *	2017-06-09	2018-12-13	Hipra Scientific, S.L.U.	Vaccine comprising clostridium toxoids
MA49771A (fr) *	2017-08-04	2020-06-10	Univ Florida	Induction d'une immunité protectrice contre des antigènes
CN107596361B (zh) *	2017-09-12	2020-08-14	浙江海隆生物科技有限公司	牛a型产气荚膜梭菌的亚单位疫苗及其制备方法和应用
CN107875377B (zh) *	2017-11-06	2020-01-03	山东农业大学	一种e型产气荚膜梭菌类毒素疫苗的制备方法
CN109954135B (zh) *	2017-12-25	2023-01-31	金宇保灵生物药品有限公司	牛a型产气荚膜梭菌灭活类毒素疫苗及其制备方法
CN111787943A (zh) *	2018-03-02	2020-10-16	一康合资有限公司	作为疫苗的来自产气荚膜梭菌的ε毒素
CN108578686B (zh) *	2018-04-23	2022-07-01	杨凌凯瑞生物科技有限公司	一种制备羊梭菌病基因工程亚单位疫苗的方法
CN109111509B (zh) *	2018-09-19	2021-08-13	天康制药(苏州)有限公司	腐败梭菌α毒素突变体、表达其的基因、制备方法和腐败梭菌疫苗
CN111500482B (zh) *	2019-01-31	2023-09-05	内蒙古金宇保灵生物技术研究院有限公司	一种羊a型产气荚膜梭菌菌株及其灭活疫苗和疫苗制备方法
CN109943507B (zh) *	2019-03-26	2021-08-17	中国兽医药品监察所	一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用
CN110041437B (zh) *	2019-04-29	2020-12-25	中国兽医药品监察所	一种无毒性破伤风毒素和诺维梭菌α毒素重组融合蛋白
CN115477699A (zh) *	2022-10-14	2022-12-16	华中农业大学	抗产气荚膜梭菌卵黄抗体及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2257230B1 (xx) *	1973-09-14	1976-11-19	Agronomique Inst Nat Rech
SU627611A1 (ru) *	1977-09-30	1980-02-05	В.П. Землякова	Вакцинный препарат в.п. земл ковой против клостридиозов животных и птиц
DK0642581T3 (da) *	1992-05-20	2003-02-17	Secr Defence	Clostridium perfringens-vacciner
DK0692974T4 (da) *	1993-03-29	2007-10-01	Pfizer	Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans
US6048535A (en) *	1997-06-12	2000-04-11	Regents Of The University Of Minnesota	Multivalent in ovo avian vaccine
CN100528225C (zh) *	2002-05-21	2009-08-19	先灵-普劳有限公司	孢子纲物种体外培养的方法及其用途
JP4771954B2 (ja) *	2003-06-09	2011-09-14	コリクサコーポレーション	Ｄｎａベクター
AU2004264355A1 (en) *	2003-08-14	2005-02-24	Merial Limited	Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
CA2583113C (en)	2004-10-05	2015-11-10	Diversa Corporation	Compositions comprising an antigen and a promiscuous t-cell epitope
MY149604A (en) *	2005-04-18	2013-09-13	Schering Plough Ltd	C.perfringens alpha toxoid vaccine
CA2669765A1 (en) *	2006-11-20	2008-05-29	Intervet International B.V.	Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

2006
- 2006-04-14 MY MYPI20061722A patent/MY149604A/en unknown
- 2006-04-17 TW TW095113660A patent/TWI311057B/zh not_active IP Right Cessation
- 2006-04-17 ES ES06750659.2T patent/ES2583484T3/es active Active
- 2006-04-17 RU RU2007142337/10A patent/RU2434638C2/ru not_active IP Right Cessation
- 2006-04-17 DK DK06750659.2T patent/DK1874344T3/en active
- 2006-04-17 MX MX2007013053A patent/MX2007013053A/es active IP Right Grant
- 2006-04-17 US US11/405,198 patent/US8980283B2/en active Active
- 2006-04-17 PE PE2006000396A patent/PE20061398A1/es not_active Application Discontinuation
- 2006-04-17 KR KR1020077026795A patent/KR20080005277A/ko not_active Abandoned
- 2006-04-17 EP EP06750659.2A patent/EP1874344B1/en active Active
- 2006-04-17 NZ NZ562637A patent/NZ562637A/en not_active IP Right Cessation
- 2006-04-17 JP JP2008507827A patent/JP5243951B2/ja active Active
- 2006-04-17 SG SG2012093878A patent/SG186672A1/en unknown
- 2006-04-17 BR BRPI0610843-1A patent/BRPI0610843B1/pt active IP Right Grant
- 2006-04-17 UA UAA200712804A patent/UA98099C2/uk unknown
- 2006-04-17 CN CN2006800218109A patent/CN101198352B/zh not_active Expired - Fee Related
- 2006-04-17 AU AU2006236365A patent/AU2006236365B2/en not_active Ceased
- 2006-04-17 WO PCT/US2006/014669 patent/WO2006113772A1/en active Application Filing
- 2006-04-17 CA CA2606180A patent/CA2606180C/en not_active Expired - Fee Related
- 2006-04-17 AR AR20060101501A patent/AR054251A1/es not_active Application Discontinuation
2007
- 2007-10-16 IL IL186701A patent/IL186701A0/en not_active IP Right Cessation
- 2007-10-16 CR CR9443A patent/CR9443A/es unknown
- 2007-10-17 TN TNP2007000387A patent/TNSN07387A1/en unknown
- 2007-10-26 MA MA30321A patent/MA29406B1/fr unknown
- 2007-11-05 ZA ZA200709516A patent/ZA200709516B/xx unknown
2011
- 2011-12-26 JP JP2011284090A patent/JP2012062330A/ja not_active Withdrawn
2015
- 2015-01-29 US US14/608,577 patent/US9662380B2/en active Active

Also Published As

Publication number	Publication date
US8980283B2 (en)	2015-03-17
US20150140033A1 (en)	2015-05-21
EP1874344A1 (en)	2008-01-09
BRPI0610843A2 (pt)	2010-07-27
EP1874344B1 (en)	2016-06-08
MX2007013053A (es)	2008-01-14
AU2006236365A1 (en)	2006-10-26
US9662380B2 (en)	2017-05-30
TW200719910A (en)	2007-06-01
JP5243951B2 (ja)	2013-07-24
CN101198352B (zh)	2011-07-27
JP2012062330A (ja)	2012-03-29
KR20080005277A (ko)	2008-01-10
CA2606180C (en)	2016-09-13
AR054251A1 (es)	2007-06-13
CR9443A (es)	2008-02-20
CN101198352A (zh)	2008-06-11
SG186672A1 (en)	2013-01-30
NZ562637A (en)	2010-06-25
MA29406B1 (fr)	2008-04-01
UA98099C2 (uk)	2012-04-25
BRPI0610843B1 (pt)	2021-11-30
CA2606180A1 (en)	2006-10-26
RU2007142337A (ru)	2009-05-27
RU2434638C2 (ru)	2011-11-27
IL186701A0 (en)	2008-02-09
PE20061398A1 (es)	2007-01-15
TWI311057B (en)	2009-06-21
AU2006236365B2 (en)	2012-02-02
JP2008536936A (ja)	2008-09-11
ES2583484T3 (es)	2016-09-21
TNSN07387A1 (en)	2009-03-17
WO2006113772A1 (en)	2006-10-26
MY149604A (en)	2013-09-13
DK1874344T3 (en)	2016-09-19
US20060233825A1 (en)	2006-10-19

Publication	Publication Date	Title
ZA200709516B (en)	2008-11-26	C. perfringens alpha toxoid vaccine
IL192084A0 (en)	2008-12-29	Vaccine
TWI365191B (en)	2012-06-01	Vaccine
GB0504436D0 (en)	2005-04-06	Vaccine
ZA200708634B (en)	2008-10-29	Novel vaccine formulations
GB0409940D0 (en)	2004-06-09	Vaccine
GB0411150D0 (en)	2004-06-23	Vaccine
ZA200709207B (en)	2009-08-26	Vaccine
GB0413510D0 (en)	2004-07-21	Vaccine
GB0515135D0 (en)	2005-08-31	Vaccine
GB0504940D0 (en)	2005-04-20	Vaccine formulation
GB0810662D0 (en)	2008-07-16	Vaccine
ZA200709210B (en)	2009-04-29	Vaccine
GB0516944D0 (en)	2005-09-28	Vaccine
GB0412407D0 (en)	2004-07-07	Vaccine
GB0419918D0 (en)	2004-10-13	Vaccine
GB0406598D0 (en)	2004-04-28	Vaccine
GB0526412D0 (en)	2006-02-08	Vaccine
GB0503000D0 (en)	2005-03-16	Anti-atheroma vaccine
GB0523445D0 (en)	2005-12-28	Vaccine
IL186591A0 (en)	2008-01-20	Vaccine
GB0509010D0 (en)	2005-06-08	Vaccine
GB0511475D0 (en)	2005-07-13	Vaccine
GB0513189D0 (en)	2005-08-03	Vaccine
IL186586A0 (en)	2008-01-20	Vaccine